These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 22682947)

  • 21. Screening for diabetes.
    Backholer K; Chen L; Shaw J
    Pathology; 2012 Feb; 44(2):110-4. PubMed ID: 22228253
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A cost analysis of community screening for diabetes in the central Wisconsin Medicare population (results from the MetaStar pilot project in Wausau).
    Lee DS; Remington P; Madagame J; Blustein J
    WMJ; 2000 Jun; 99(3):39-43. PubMed ID: 10927980
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Should all patients with nonalcoholic fatty liver disease undergo oral glucose tolerance test?
    Wong VW; Chan HL
    J Gastroenterol Hepatol; 2011 Mar; 26(3):419-20. PubMed ID: 21332536
    [No Abstract]   [Full Text] [Related]  

  • 24. [Prevalence of postpartum impaired glucose tolerance after gestational diabetes].
    Romero Gutiérrez G; Macias Rocha AL; Puente Alvarez EI
    Ginecol Obstet Mex; 2012 Oct; 80(10):631-6. PubMed ID: 23240225
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of abnormal glucose tolerance in Khon Kaen Province and validity of urine stick and fasting blood sugar as screening tools.
    Chaisiri K; Pongpaew P; Tungtrongchitr R; Phonrat B; Kulleap S; Kuhathong C; Sutthiwong P; Intarakhao C; Mahaweerawat U; Khongdee W; Sanchaisuriya P; Saowakontha S; Merkle A; Schelp FP
    J Med Assoc Thai; 1997 Jun; 80(6):363-71. PubMed ID: 9240010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Known diabetes and fasting hyperglycaemia in the elderly. Prevalence and economic impact upon health services.
    Damsgaard EM
    Dan Med Bull; 1990 Dec; 37(6):530-46. PubMed ID: 2073856
    [No Abstract]   [Full Text] [Related]  

  • 27. A type 2 diabetes screening program by general practioners in a Belgian at risk population.
    Buysschaert M; Vandenbroucke C; Barsoum S
    Diabetes Metab; 2001 Apr; 27(2 Pt 1):109-14. PubMed ID: 11353875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Definition and diagnosis of IFG, IGT and borderline type].
    Kawazu S
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():43-8. PubMed ID: 15779343
    [No Abstract]   [Full Text] [Related]  

  • 29. The ADDITION study: proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with Type 2 diabetes detected by screening.
    Lauritzen T; Griffin S; Borch-Johnsen K; Wareham NJ; Wolffenbuttel BH; Rutten G;
    Int J Obes Relat Metab Disord; 2000 Sep; 24 Suppl 3():S6-11. PubMed ID: 11063279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Maximizing efficiency and cost-effectiveness of Type 2 diabetes screening: the AusDiab study.
    Chen L; Magliano DJ; Balkau B; Wolfe R; Brown L; Tonkin AM; Zimmet PZ; Shaw JE
    Diabet Med; 2011 Apr; 28(4):414-23. PubMed ID: 21392062
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral glucose tolerance test in Italian overweight/obese children and adolescents results in a very high prevalence of impaired fasting glycaemia, but not of diabetes.
    Cambuli VM; Incani M; Pilia S; Congiu T; Cavallo MG; Cossu E; Sentinelli F; Mariotti S; Loche S; Baroni MG
    Diabetes Metab Res Rev; 2009 Sep; 25(6):528-34. PubMed ID: 19496065
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impaired glucose tolerance, impaired fasting glycaemia and cardiovascular risk.
    Sanusi H
    Acta Med Indones; 2004; 36(1):36-41. PubMed ID: 15673935
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prevalence of impaired glucose metabolism in Hispanics with two or more risk factors for metabolic syndrome in the primary care setting.
    Neira CP; Hartig M; Cowan PA; Velasquez-Mieyer PA
    J Am Acad Nurse Pract; 2009 Mar; 21(3):173-8. PubMed ID: 19302694
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiometabolic profile of people screened for high risk of type 2 diabetes in a national diabetes prevention programme (FIN-D2D).
    Saaristo T; Moilanen L; Jokelainen J; Korpi-Hyövälti E; Vanhala M; Saltevo J; Niskanen L; Peltonen M; Oksa H; Cederberg H; Tuomilehto J; Uusitupa M; Keinänen-Kiukaanniemi S
    Prim Care Diabetes; 2010 Dec; 4(4):231-9. PubMed ID: 21134669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Period prevalence of abnormal glucose tolerance and cardiovascular risk factors among obese children attending an obesity centre in Italy.
    Invitti C; Gilardini L; Pontiggia B; Morabito F; Mazzilli G; Viberti G
    Nutr Metab Cardiovasc Dis; 2006 May; 16(4):256-62. PubMed ID: 16679217
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prevalence of the glucose metabolism disturbances in screening of adult inhabitants of Krakow].
    Szurkowska M; Szafraniec K; Gilis-Januszewska A; Pach D; Krzentowska A; Szybiński Z; Huszno B
    Przegl Lek; 2006; 63(9):728-32. PubMed ID: 17479858
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clustering of coronary artery disease risk factors in patients with type 2 diabetes and impaired glucose tolerance.
    Sajjadi F; Mohammadifard N; Kelishadi R; Ghaderian N; Alikhasi H; Maghrun M
    East Mediterr Health J; 2008; 14(5):1080-9. PubMed ID: 19161080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Screening and intervention. A strategy in type 2 diabetes?].
    Jørgensen T; Glümer C; Borch-Johnsen K
    Ugeskr Laeger; 2002 Apr; 164(16):2135-9. PubMed ID: 11989055
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Santa Barbara County Health Care Services program: birth weight change concomitant with screening for and treatment of glucose-intolerance of pregnancy: a potential cost-effective intervention?
    Jovanovic-Peterson L; Bevier W; Peterson CM
    Am J Perinatol; 1997 Apr; 14(4):221-8. PubMed ID: 9259932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Poor reproducibility of the oral glucose tolerance test in the diagnosis of diabetes during percutaneous coronary intervention.
    Jiménez-Navarro MF; Garcia-Pinilla JM; Garrido-Sanchez L; Alonso-Briales JH; Pérez-Cabeza A; Ortiz-García C; Hernández-Garcia JM; Tinahones F; de Teresa E
    Int J Cardiol; 2010 Jul; 142(3):245-9. PubMed ID: 19232754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.